Genzyme Defeats 1 Of 3 Defenses In Hectorol IP Suit
A federal judge has dismissed one inequitable conduct defense asserted by Cobrek Pharmaceuticals Inc. in a patent infringement suit brought by Genzyme Corp. over kidney disease treatment Hectorol, but left two...To view the full article, register now.
Already a subscriber? Click here to view full article